ModivCare Inc. Faces Class Action Lawsuit and Financial Challenges

  • ModivCare Inc. (NASDAQ:MODV) is involved in a class action lawsuit due to alleged securities fraud, impacting its stock performance and financial health.
  • The company's financial metrics reveal significant challenges, including a negative price-to-earnings ratio and concerns regarding liquidity and cash flow generation.
  • ModivCare's debt situation is precarious, with a notably negative debt-to-equity ratio, further complicating its financial stability amidst the lawsuit.

ModivCare Inc. (NASDAQ:MODV) is currently facing a class action securities lawsuit, with shareholders being urged to contact the law firm Levi & Korsinsky by March 31, 2025. The lawsuit alleges that ModivCare engaged in securities fraud, negatively impacting shareholders between November 3, 2022, and September 15, 2024. The company is accused of making false statements and concealing issues in its Non-Emergency Medical Transportation (NEMT) segment, which led to a decline in free cash flow.

The financial challenges faced by ModivCare are evident in its current stock performance. On March 7, 2025, Barrington set a price target of $6 for MODV, while the stock was trading at $2.75, indicating a significant price difference of approximately 81.82%. This suggests that the market has a more pessimistic view of the company's prospects compared to the target set by Barrington.

ModivCare's financial metrics further highlight its struggles. The company has a negative price-to-earnings (P/E) ratio of -0.18, indicating ongoing losses. Its price-to-sales ratio is low at 0.013, suggesting that the stock is valued at a fraction of its sales. Additionally, the enterprise value to sales ratio is 0.086, reflecting the company's valuation in relation to its revenue.

The company's liquidity and cash flow generation are also concerning. The enterprise value to operating cash flow ratio is significantly negative at -37.40, highlighting challenges in generating cash flow from operations. The current ratio of 0.79 suggests potential liquidity issues, as the company may struggle to cover its short-term liabilities with its current assets.

ModivCare's debt situation is another area of concern. The debt-to-equity ratio is notably negative at -8.21, indicating a high level of debt relative to equity. This financial instability, combined with the ongoing lawsuit, presents significant challenges for the company and its shareholders.

Symbol Price %chg
SRAJ.JK 4200 0
MIKA.JK 2510 0
SILO.JK 2220 0
HEAL.JK 1495 0
MODV Ratings Summary
MODV Quant Ranking
Related Analysis

ModivCare Inc. Faces Class Action Lawsuit and Financial Challenges

  • ModivCare Inc. (NASDAQ:MODV) is involved in a class action lawsuit due to alleged securities fraud, impacting its stock performance and financial health.
  • The company's financial metrics reveal significant challenges, including a negative price-to-earnings ratio and concerns regarding liquidity and cash flow generation.
  • ModivCare's debt situation is precarious, with a notably negative debt-to-equity ratio, further complicating its financial stability amidst the lawsuit.

ModivCare Inc. (NASDAQ:MODV) is currently facing a class action securities lawsuit, with shareholders being urged to contact the law firm Levi & Korsinsky by March 31, 2025. The lawsuit alleges that ModivCare engaged in securities fraud, negatively impacting shareholders between November 3, 2022, and September 15, 2024. The company is accused of making false statements and concealing issues in its Non-Emergency Medical Transportation (NEMT) segment, which led to a decline in free cash flow.

The financial challenges faced by ModivCare are evident in its current stock performance. On March 7, 2025, Barrington set a price target of $6 for MODV, while the stock was trading at $2.75, indicating a significant price difference of approximately 81.82%. This suggests that the market has a more pessimistic view of the company's prospects compared to the target set by Barrington.

ModivCare's financial metrics further highlight its struggles. The company has a negative price-to-earnings (P/E) ratio of -0.18, indicating ongoing losses. Its price-to-sales ratio is low at 0.013, suggesting that the stock is valued at a fraction of its sales. Additionally, the enterprise value to sales ratio is 0.086, reflecting the company's valuation in relation to its revenue.

The company's liquidity and cash flow generation are also concerning. The enterprise value to operating cash flow ratio is significantly negative at -37.40, highlighting challenges in generating cash flow from operations. The current ratio of 0.79 suggests potential liquidity issues, as the company may struggle to cover its short-term liabilities with its current assets.

ModivCare's debt situation is another area of concern. The debt-to-equity ratio is notably negative at -8.21, indicating a high level of debt relative to equity. This financial instability, combined with the ongoing lawsuit, presents significant challenges for the company and its shareholders.

ModivCare Inc. (NASDAQ:MODV) Faces Financial Challenges Ahead of Earnings Release

  • ModivCare Inc. (NASDAQ:MODV) is set to release its quarterly earnings on March 6, 2025, with analysts expecting an EPS loss of $0.10 and projected revenue of $703.3 million.
  • The company is dealing with a class action securities lawsuit alleging false statements about its NEMT segment, impacting its financial health.
  • Key financial metrics indicate challenges: a negative P/E ratio of -0.24, a low price-to-sales ratio of 0.016, and significant debt with a debt-to-equity ratio of -74.27.

ModivCare Inc. (NASDAQ:MODV) provides a range of healthcare services, including Non-Emergency Medical Transportation (NEMT). As a key player in the healthcare sector, ModivCare faces competition from other companies offering similar services. On March 6, 2025, MODV is set to release its quarterly earnings, with Wall Street analysts estimating an earnings per share loss of $0.10 and projected revenue of approximately $703.3 million.

The company's financial challenges are underscored by a class action securities lawsuit filed against it. The lawsuit alleges that ModivCare made false statements or concealed information about contracts in its NEMT segment, leading to a deterioration in free cash flow. This situation resulted in contract renegotiations and pricing accommodations, negatively impacting the company's financial health.

MODV's financial metrics reflect its current struggles. The company has a negative price-to-earnings (P/E) ratio of -0.24, indicating negative earnings relative to its share price. Its price-to-sales ratio is a low 0.016, suggesting that the market values its sales modestly. The enterprise value to sales ratio is 0.45, reflecting the company's valuation in relation to its revenue.

The enterprise value to operating cash flow ratio is notably negative at -20.27, indicating challenges in generating cash flow from operations. The earnings yield is -4.10%, further highlighting the company's financial difficulties. Additionally, MODV has a debt-to-equity ratio of -74.27, suggesting a significant level of debt compared to its equity, and a current ratio of 0.80, indicating potential liquidity concerns.

ModivCare Inc. (NASDAQ:MODV) Faces Financial Challenges Ahead of Earnings Release

  • ModivCare Inc. (NASDAQ:MODV) is set to release its quarterly earnings on March 6, 2025, with analysts expecting an EPS loss of $0.10 and projected revenue of $703.3 million.
  • The company is dealing with a class action securities lawsuit alleging false statements about its NEMT segment, impacting its financial health.
  • Key financial metrics indicate challenges: a negative P/E ratio of -0.24, a low price-to-sales ratio of 0.016, and significant debt with a debt-to-equity ratio of -74.27.

ModivCare Inc. (NASDAQ:MODV) provides a range of healthcare services, including Non-Emergency Medical Transportation (NEMT). As a key player in the healthcare sector, ModivCare faces competition from other companies offering similar services. On March 6, 2025, MODV is set to release its quarterly earnings, with Wall Street analysts estimating an earnings per share loss of $0.10 and projected revenue of approximately $703.3 million.

The company's financial challenges are underscored by a class action securities lawsuit filed against it. The lawsuit alleges that ModivCare made false statements or concealed information about contracts in its NEMT segment, leading to a deterioration in free cash flow. This situation resulted in contract renegotiations and pricing accommodations, negatively impacting the company's financial health.

MODV's financial metrics reflect its current struggles. The company has a negative price-to-earnings (P/E) ratio of -0.24, indicating negative earnings relative to its share price. Its price-to-sales ratio is a low 0.016, suggesting that the market values its sales modestly. The enterprise value to sales ratio is 0.45, reflecting the company's valuation in relation to its revenue.

The enterprise value to operating cash flow ratio is notably negative at -20.27, indicating challenges in generating cash flow from operations. The earnings yield is -4.10%, further highlighting the company's financial difficulties. Additionally, MODV has a debt-to-equity ratio of -74.27, suggesting a significant level of debt compared to its equity, and a current ratio of 0.80, indicating potential liquidity concerns.